• In English
• Suomeksi

2009 © Institute for Molecular Medicine Finland FIMM

National Network for Molecular Medicine

FIMM has formed a National Network for Molecular Medicine composed of 15 top quality molecular medicine experts in Finland. Members for the molecular medicine network were selected from an open call by a Search Committee chaired by the EMBL Director General, Professor Iain Mattaj.

FIMM offers specific translational research grants for the members of the network meant to foster collaborations with FIMM and the development of translational studies, such as proof-of concept diagnostic and therapeutic projects. These projects should be non-overlapping with existing research projects. The network meets 2-3 times a year. The first Network meeting was arranged in September 2008.

Principal Investigators and their FIMM-specific research projects

• Academy Professor Lauri A. Aaltonen, University of Helsinki
  Array-based analysis of paraffin-embedded tissue materials
• Academy Professor Kari Alitalo, University of Helsinki
  Inhibitors of the oncogenic Prox1 pathway in human tumors
• Professor Willem de Vos, University of Helsinki and Wageningen University (NL)
• Professor Akseli Hemminki, University of Helsinki and HUS
  Translational cancer gene therapy for induction of antitumor immunity
• Assoc. Professor Iiris Hovatta, University of Helsinki
  The role of miRNAs in the regulation of anxiety
• Professor Elina Ikonen, University of Helsinki
  High-throughput screening of sterol distribution in cell membranes: use of fluorescent lipid derivatives
• Professor Sirpa Jalkanen, University of Turku and THL
  Role of trafficking molecules in cancer spread and harmful inflammations
• Professor Heikki Joensuu, University of Helsinki and HUS
• Professor Jaakko Kaprio, University of Helsinki and THL
• Assoc. Professor Heli Nevanlinna, HUS
  Novel genes and gene interactions in breast cancer risk and progression
• Professor Matej Oresic, VTT
  Metabolic stress and autoimmunity in health and disease
• Professor Taina Pihlajaniemi, University of Oulu
  Translational Genome-Scale Biology
• Academy Professor Jussi Taipale, University of Helsinki and THL
• Professor Anu Wartiovaara, University of Helsinki
  Mitochondrial function as a risk factor and as a protective trait in metabolic syndrome, cardiovascular events, and neurodegeneration
• Assoc. Professor Jukka Westermarck, University of Turku
  Targeting protein-protein interactions for cancer therapy